These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 19861430

  • 1. Successful use of topical voriconazole 1% alone as first-line antifungal therapy against Candida albicans keratitis.
    Al-Badriyeh D, Leung L, Davies GE, Stewart K, Kong D.
    Ann Pharmacother; 2009 Dec; 43(12):2103-7. PubMed ID: 19861430
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Topical and oral voriconazole in the treatment of fungal keratitis.
    Lee SJ, Lee JJ, Kim SD.
    Korean J Ophthalmol; 2009 Mar; 23(1):46-8. PubMed ID: 19337480
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Voriconazole in the management of Alternaria keratitis.
    Ozbek Z, Kang S, Sivalingam J, Rapuano CJ, Cohen EJ, Hammersmith KM.
    Cornea; 2006 Feb; 25(2):242-4. PubMed ID: 16371794
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis.
    Thiel MA, Zinkernagel AS, Burhenne J, Kaufmann C, Haefeli WE.
    Antimicrob Agents Chemother; 2007 Jan; 51(1):239-44. PubMed ID: 17060517
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Voriconazole versus natamycin as primary treatment in fungal corneal ulcers.
    Arora R, Gupta D, Goyal J, Kaur R.
    Clin Exp Ophthalmol; 2011 Jul; 39(5):434-40. PubMed ID: 21105974
    [Abstract] [Full Text] [Related]

  • 14. Voriconazole and fungal keratitis: a report of two treatment failures.
    Giaconi JA, Marangon FB, Miller D, Alfonso EC.
    J Ocul Pharmacol Ther; 2006 Dec; 22(6):437-9. PubMed ID: 17238810
    [Abstract] [Full Text] [Related]

  • 15. Prospective open-label study of the administration of two-percent voriconazole eye drops.
    Al-Badriyeh D, Leung L, Roydhouse T, Fullinfaw R, Daniell M, Davies GE, Stewart K, Kong DC.
    Antimicrob Agents Chemother; 2009 Jul; 53(7):3153-5. PubMed ID: 19433565
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Factors affecting treatment outcomes with voriconazole in cases with fungal keratitis.
    Ramakrishnan T, Constantinou M, Jhanji V, Vajpayee RB.
    Cornea; 2013 Apr; 32(4):445-9. PubMed ID: 22580440
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of intrastromal voriconazole injection in recalcitrant deep fungal keratitis: case series.
    Sharma N, Agarwal P, Sinha R, Titiyal JS, Velpandian T, Vajpayee RB.
    Br J Ophthalmol; 2011 Dec; 95(12):1735-7. PubMed ID: 21454381
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.